Evaluation of Chimpanzee Adenovirus and MVA Expressing TRAP and CSP from <i>Plasmodium cynomolgi</i> to Prevent Malaria Relapse in Nonhuman Primates
<i>Plasmodium vivax</i> is the world’s most widely distributed human malaria parasite, with over 2.8 billion people at risk in Asia, the Americas, and Africa. The 80–90% new <i>P. vivax</i> malaria infections are due to relapses which suggest that a vaccine with high efficacy...
Main Authors: | Young Chan Kim, Barbara Dema, Roberto Rodriguez-Garcia, César López-Camacho, Fabiana M. S. Leoratti, Amar Lall, Edmond J. Remarque, Clemens H. M. Kocken, Arturo Reyes-Sandoval |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/3/363 |
Similar Items
-
Evaluation of chimpanzee adenovirus and MVA expressing TRAP and CSP from Plasmodium cynomolgi to prevent malaria relapse in nonhuman primates
by: Kim, YC, et al.
Published: (2020) -
Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon
by: Lilian Rose Pratt-Riccio, et al. -
Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites
by: Catherin Marin-Mogollon, et al.
Published: (2018-08-01) -
Structural basis of Plasmodium vivax inhibition by antibodies binding to the circumsporozoite protein repeats
by: Iga Kucharska, et al.
Published: (2022-01-01) -
A Multistage Formulation Based on Full-Length CSP and AMA-1 Ectodomain of <i>Plasmodium vivax</i> Induces High Antibody Titers and T-cells and Partially Protects Mice Challenged with a Transgenic <i>Plasmodium berghei</i> Parasite
by: Luciana C. Lima, et al.
Published: (2020-06-01)